Allogene Therapeutics (ALLO)
(Delayed Data from NSDQ)
$2.16 USD
-0.17 (-7.30%)
Updated Jul 2, 2024 04:00 PM ET
After-Market: $2.16 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
F Value D Growth A Momentum F VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
08/07/2024
Time: -- |
6/2024 | $-0.35 | -3.30% |
Earnings Summary
For their last quarter, Allogene Therapeutics (ALLO) reported earnings of -$0.38 per share, in line with the Zacks Consensus Estimate. This reflects a breakeven earnings surprise. Look out for ALLO's next earnings release expected on August 07, 2024. For the next earning release, we expect the company to report earnings of -$0.35 per share, reflecting a year-over-year increase of 33.96%.
Earnings History
Price & Consensus
Zacks News for ALLO
Allogene (ALLO) Q1 Earnings in Line With Estimates, Sales Lag
ALLO: What are Zacks experts saying now?
Zacks Private Portfolio Services